Michael Rapp, 10% Owner at Zynerba Pharmaceuticals, Inc. (ZYNE), bought 170,000 shares at $9.94 ($1.7M) on 2017-10-23, disclosed to the SEC on 2017-10-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.59 | 44,255 | $424K | 25.7% |
| 2 | $9.59 | 44,255 | $424K | 25.7% |
| 3 | $9.78 | 30,000 | $293K | 17.7% |
| 4 | $9.94 | 25,745 | $256K | 15.5% |
| 5 | $9.94 | 25,745 | $256K | 15.5% |
| Total | $9.73 avg | 170,000 |
| $1.7M |
| 100% |
| Filing → |
| IMNM | BUY | 2021-05-26 | $1.9M | — | Filing → |
| IMNM | BUY | 2020-10-08 | $1000K | — | Filing → |
| ZYNE | BUY | 2018-05-31 | $123K | — | Filing → |